BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 23810574)

  • 1. Tumor recurrence is independent of pancreatic fistula in patients after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
    Assifi MM; Zhang S; Leiby BE; Pequignot EC; Xia B; Rosato E; Lavu H; Kennedy EP; Yeo CJ; Berger AC
    J Am Coll Surg; 2013 Oct; 217(4):621-7. PubMed ID: 23810574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrence pattern and prognosis of pancreatic cancer after pancreatic fistula.
    Nagai S; Fujii T; Kodera Y; Kanda M; Sahin TT; Kanzaki A; Hayashi M; Sugimoto H; Nomoto S; Takeda S; Morita S; Nakao A
    Ann Surg Oncol; 2011 Aug; 18(8):2329-37. PubMed ID: 21327822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Life-threatening postoperative pancreatic fistula (grade C) after pancreaticoduodenectomy: incidence, prognosis, and risk factors.
    Fuks D; Piessen G; Huet E; Tavernier M; Zerbib P; Michot F; Scotte M; Triboulet JP; Mariette C; Chiche L; Salame E; Segol P; Pruvot FR; Mauvais F; Roman H; Verhaeghe P; Regimbeau JM
    Am J Surg; 2009 Jun; 197(6):702-9. PubMed ID: 18778804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Pancreatic Fistula on Recurrence and Long-Term Prognosis of Periampullary Adenocarcinomas after Pancreaticoduodenectomy.
    Serrano PE; Kim D; Kim PT; Greig PD; Moulton CA; Gallinger S; Wei AC; Cleary SP
    Am Surg; 2016 Dec; 82(12):1187-1195. PubMed ID: 28234183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of pancreatic fistula and postoperative complications after pancreaticoduodenectomy in patients with pancreatic ductal adenocarcinoma.
    Neeman U; Lahat G; Goykhman Y; Geva R; Peles-Avraham S; Nachmany I; Nakache R; Klausner JM; Lubezky N
    Surgeon; 2020 Feb; 18(1):24-30. PubMed ID: 31466841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic fistula after a pancreaticoduodenectomy for ductal adenocarcinoma and its association with morbidity: a multicentre study of the French Surgical Association.
    Addeo P; Delpero JR; Paye F; Oussoultzoglou E; Fuchshuber PR; Sauvanet A; Sa Cunha A; Le Treut YP; Adham M; Mabrut JY; Chiche L; Bachellier P;
    HPB (Oxford); 2014 Jan; 16(1):46-55. PubMed ID: 23461663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors of pancreatic fistula after pancreaticoduodenectomy - patients with low drain amylase level on postoperative day 1 are safe from developing pancreatic fistula.
    Tsujie M; Nakamori S; Miyamoto A; Yasui M; Ikenaga M; Hirao M; Fujitani K; Mishima H; Tsujinaka T
    Hepatogastroenterology; 2012; 59(120):2657-60. PubMed ID: 22497944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Follow-up after curative surgery for pancreatic ductal adenocarcinoma: asymptomatic recurrence is associated with improved survival.
    Nordby T; Hugenschmidt H; Fagerland MW; Ikdahl T; Buanes T; Labori KJ
    Eur J Surg Oncol; 2013 Jun; 39(6):559-66. PubMed ID: 23498362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative serum C-reactive protein levels and post-operative lymph node ratio are important predictors of survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
    Sanjay P; de Figueiredo RS; Leaver H; Ogston S; Kulli C; Polignano FM; Tait IS
    JOP; 2012 Mar; 13(2):199-204. PubMed ID: 22406601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical appraisal of 232 consecutive distal pancreatectomies with emphasis on risk factors, outcome, and management of the postoperative pancreatic fistula: a 21-year experience at a single institution.
    Goh BK; Tan YM; Chung YF; Cheow PC; Ong HS; Chan WH; Chow PK; Soo KC; Wong WK; Ooi LL
    Arch Surg; 2008 Oct; 143(10):956-65. PubMed ID: 18936374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metastatic lymph node ratio as an important prognostic factor in pancreatic ductal adenocarcinoma.
    Robinson SM; Rahman A; Haugk B; French JJ; Manas DM; Jaques BC; Charnley RM; White SA
    Eur J Surg Oncol; 2012 Apr; 38(4):333-9. PubMed ID: 22317758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superior Mesenteric Artery Margin of Posttherapy Pancreaticoduodenectomy and Prognosis in Patients With Pancreatic Ductal Adenocarcinoma.
    Liu L; Katz MH; Lee SM; Fischer LK; Prakash L; Parker N; Wang H; Varadhachary GR; Wolff RA; Lee JE; Pisters PW; Maitra A; Fleming JB; Estrella J; Rashid A; Wang H
    Am J Surg Pathol; 2015 Oct; 39(10):1395-403. PubMed ID: 26200098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreaticogastrostomy decreased relaparotomy caused by pancreatic fistula after pancreaticoduodenectomy compared with pancreaticojejunostomy.
    Oussoultzoglou E; Bachellier P; Bigourdan JM; Weber JC; Nakano H; Jaeck D
    Arch Surg; 2004 Mar; 139(3):327-35. PubMed ID: 15006893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes mellitus does not impact on clinically relevant pancreatic fistula after partial pancreatic resection for ductal adenocarcinoma.
    Malleo G; Mazzarella F; Malpaga A; Marchegiani G; Salvia R; Bassi C; Butturini G
    Surgery; 2013 May; 153(5):641-50. PubMed ID: 23276391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triple-layer duct-to-mucosa pancreaticojejunostomy with resection of jejunal serosa decreased pancreatic fistula after pancreaticoduodenectomy.
    Su AP; Zhang Y; Ke NW; Lu HM; Tian BL; Hu WM; Zhang ZD
    J Surg Res; 2014 Jan; 186(1):184-91. PubMed ID: 24095023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors influencing outcome in patients undergoing portal vein resection for adenocarcinoma of the pancreas.
    Banz VM; Croagh D; Coldham C; Tanière P; Buckels J; Isaac J; Mayer D; Muiesan P; Bramhall S; Mirza DF
    Eur J Surg Oncol; 2012 Jan; 38(1):72-9. PubMed ID: 22054617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors affecting survival after pancreaticoduodenectomy for pancreatic adenocarcinoma (single center experience).
    El Nakeeb A; El Shobary M; El Dosoky M; Nabeh A; El Sorogy M; El Eneen AA; abu Zeid M; Elwahab MA
    Hepatogastroenterology; 2014; 61(133):1426-38. PubMed ID: 25436321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does type of pancreaticojejunostomy after pancreaticoduodenectomy decrease rate of pancreatic fistula? A randomized, prospective, dual-institution trial.
    Berger AC; Howard TJ; Kennedy EP; Sauter PK; Bower-Cherry M; Dutkevitch S; Hyslop T; Schmidt CM; Rosato EL; Lavu H; Nakeeb A; Pitt HA; Lillemoe KD; Yeo CJ
    J Am Coll Surg; 2009 May; 208(5):738-47; discussion 747-9. PubMed ID: 19476827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe postoperative complications decrease overall and disease free survival in pancreatic ductal adenocarcinoma after pancreaticoduodenectomy.
    Lubrano J; Bachelier P; Paye F; Le Treut YP; Chiche L; Sa-Cunha A; Turrini O; Menahem B; Launoy G; Delpero JR
    Eur J Surg Oncol; 2018 Jul; 44(7):1078-1082. PubMed ID: 29685757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatogastrostomy as a salvage procedure to treat severe postoperative pancreatic fistula after pancreatoduodenectomy.
    Bachellier P; Oussoultzoglou E; Rosso E; Scurtu R; Lucescu I; Oshita A; Jaeck D
    Arch Surg; 2008 Oct; 143(10):966-70; discussion 971. PubMed ID: 18936375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.